Rapid approach to the quantitative determination of topiramate (2, 3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry.
暂无分享,去创建一个
[1] P. Carvey,et al. Analysis of 9-fluorenylmethyloxycarbonyl derivatives of catecholamines by high performance liquid chromatography, liquid chromatography/mass spectrometry and tandem mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.
[2] M. Trimble,et al. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs , 1999, Seizure.
[3] D. Schaufelberger,et al. Determination of the inorganic degradation products sulfate and sulfamate in the antiepileptic drug topiramate by capillary electrophoresis. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[4] R. Shank,et al. In vivo microdialysis and liquid chromatography/thermospray mass spectrometry of the novel anticonvulsant 2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate (topiramate) in rat brain fluid. , 1998, Journal of mass spectrometry : JMS.
[5] K. Li,et al. Negative ion liquid secondary ion mass spectrometry and tandem mass spectrometric analysis of the molecular species of aminophospholipids as 9-fluorenylmethyloxycarbonyl derivatives , 1996 .
[6] C. B. Davis,et al. Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant , 1994, Epilepsia.
[7] M. Bialer. Comparative Pharmacokinetics of the Newer Antiepileptic Drugs , 1993, Clinical pharmacokinetics.
[8] M. Holland,et al. Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma. , 1988, Journal of chromatography.